Subversive subjects: rule-breaking and deception in clinical trials.
Research subjects do not always conform to research requirements. When their personal interests conflict with the demands of participation, some subjects surreptitiously break the rules. These subjects are subversive--they undermine the research endeavor. In rejecting the restrictions research imposes, subversive subjects diminish the value of research results. From one vantage point, subversive subjects engage in unethical behavior. They create risks to themselves and others; they also disregard ethical responsibilities to adhere to research agreements and tell the truth. At the same time, subversive subjects expose ethical problems in the design and conduct of clinical trials. Features of the research environment create fertile ground for subject subversion. Intensified policing and guidance are two common strategies for reducing subject subversion, but collaborative reforms are more consistent with the partnership model of clinical research.
Daniel Noyes Kirby Professor of Law and Professor of Ethics in Medicine at Washington University in St. Louis.
Rebecca
R
Dresser
D002986:Clinical Trials as Topic; D008192:Deception; D032984:Ethics, Research; D006801:Humans; D055118:Medication Adherence; D035842:Research Subjects